Skip to main content
SpringerLink
Log in
Book cover

New Anticancer Drugs

Fourth Annual Program Review Symposium on Phase I and II in Clinical Trials, Tokyo, Japan, June 5-6, 1978. US Japan Agreement on Cancer Research

  • Book
  • © 1980

Overview

Editors:
  1. Stephen K. Carter

    1. Northern California Cancer Program, Palo Alto, USA

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. Yoshia Sakurai

    1. Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Toshima-ku, Tokyo 170, Japan

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Recent Results in Cancer Research (RECENTCANCER, volume 70)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (23 chapters)

  1. Front Matter

    Pages I-XI
    Download chapter PDF

  2. Introduction of U.S.-Japan Joint Meeting on Phase I and II Clinical Trials

    • Stephen K. Carter
    Pages 1-3

  3. The New NCI Screen and Its Implications for Clinical Evaluation

    • Abraham Goldin, John M. Venditti
    Pages 5-20

  4. The National Cancer Institute’s Natural Products Antineoplastic Development Program

    • John Douros, Matthew Suffness
    Pages 21-44

  5. Methodology of Phase I Study in Japan

    • Makoto Ogawa
    Pages 45-51

  6. Methodology of Phase II Clinical Trial in Cancer

    • Franco M. Muggia, Marcel Rozencweig, Maurice J. Staquet, William P. McGuire Jr.
    Pages 53-60

  7. Phase II Study of Antineoplastic Agents in Japan

    • Hisashi Majima
    Pages 61-65

  8. Clinical Strategy for Evaluation of Anthracycline Analogues

    • Robert S. Benjamin
    Pages 67-73

  9. Preliminary Clinical Study of Aclacinomycin A

    • Hisashi Majima
    Pages 75-81

  10. Preclinical and Clinical Studies on Chlorozotocin, a New Nitrosourea with Decreased Bone Marrow Toxicity

    • John S. Macdonald, Daniel Hoth, Philip S. Schein
    Pages 83-89

  11. Continuation of Phase II Study of 1-(4-Amino-2-Methylpyrimidine-5-yl)-Methyl-3-(2-Chloroethyl)-3-Nitrosourea Hydrochloride (ACNU)

    • Tatuo Saito
    Pages 91-106

  12. Review of Experimental Studies on Nitrosourea Derivatives in Japan

    • Shigeru Tsukagoshi
    Pages 107-117

  13. The Clinical Evaluation of Analogues, IV. Nitrosoureas

    • Stephen K. Carter
    Pages 119-123

  14. Review of a New Antimetabolic Agent 1-Hexylcarbamoyl-5-Fluorouracil (HCFU)

    • Tetsuo Taguchi
    Pages 125-132

  15. Review of a New Antimetabolic Agent, 1,3-Bis(Tetrahydro-2-Furanyl)-5-Fluoro-2,4-Pyrimidinedione (FD-1)

    • Tetsuo Taguchi
    Pages 133-145

  16. Effect and Mode of Action of N4-Behenoyl-β-D-Arabinofuranosylcytosine

    • Tateshi Kataoka, Yoshio Sakurai
    Pages 147-151

  17. Strategy for Evaluation of a New Antitumor Agent in the Treatment of Breast Cancer

    • Robert S. Benjamin, Gabriel N. Hortobagyi, Kenneth D. Swenerton, George R. Blumenschein, Gerald P. Bodey
    Pages 153-157

  18. Current Status of Breast Cancer Chemotherapy in Japan

    • Hiroki Koyama
    Pages 159-166

  19. Present Status of Lung Cancer Chemotherapy in Japan

    • Kazuo Ota, Minora Nishimura
    Pages 167-177

  20. Clinical Strategies in the Chemotherapy of Gastrointestinal Cancer

    • John S. Macdonald, Paul V. Woolley, Philip S. Schein
    Pages 179-185
Back to top

Keywords

Editors and Affiliations

  • Northern California Cancer Program, Palo Alto, USA

    Stephen K. Carter

  • Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Toshima-ku, Tokyo 170, Japan

    Yoshia Sakurai

Bibliographic Information

  • Book Title: New Anticancer Drugs

  • Book Subtitle: Fourth Annual Program Review Symposium on Phase I and II in Clinical Trials, Tokyo, Japan, June 5-6, 1978. US Japan Agreement on Cancer Research

  • Editors: Stephen K. Carter, Yoshia Sakurai

  • Series Title: Recent Results in Cancer Research

  • DOI: https://doi.org/10.1007/978-3-642-81392-4

  • Publisher: Springer Berlin, Heidelberg

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag Berlin Heidelberg 1980

  • Softcover ISBN: 978-3-642-81394-8Published: 08 December 2011

  • eBook ISBN: 978-3-642-81392-4Published: 06 December 2012

  • Series ISSN: 0080-0015

  • Series E-ISSN: 2197-6767

  • Edition Number: 1

  • Number of Pages: XII, 232

  • Number of Illustrations: 5 b/w illustrations

  • Topics: Oncology, Pharmacology/Toxicology

Publish with us

Policies and ethics

Back to top

Search

Navigation